Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Dodds

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The International Journal of Neuropsychopharmacology|January 11, 2014
Late cortical plasticity in motor and auditory cortex: role of met-allele in BDNF Val66Met polymorphismJames T H Teo, Graham Bentley, Philip Lawrence, et al.
Plos One|December 21, 2013
Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophreniaMuzaffer Kaser, Fruzsina Soltesz, Phil Lawrence, et al.
Biological Psychiatry|December 19, 2012
Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese peopleVictoria C Cambridge, Hisham Ziauddeen, Pradeep J Nathan, et al.
Journal of Clinical Pharmacology|August 13, 2013
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsHisham Ziauddeen, Pradeep J Nathan, Chris Dodds, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 10, 2018
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 GenotypeHisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 26, 2016
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 GenotypeHisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The International Journal of Neuropsychopharmacology|January 11, 2014
Late cortical plasticity in motor and auditory cortex: role of met-allele in BDNF Val66Met polymorphismJames T H Teo, Graham Bentley, Philip Lawrence, et al.
Plos One|December 21, 2013
Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophreniaMuzaffer Kaser, Fruzsina Soltesz, Phil Lawrence, et al.
Biological Psychiatry|December 19, 2012
Neural and behavioral effects of a novel mu opioid receptor antagonist in binge-eating obese peopleVictoria C Cambridge, Hisham Ziauddeen, Pradeep J Nathan, et al.
Journal of Clinical Pharmacology|August 13, 2013
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjectsHisham Ziauddeen, Pradeep J Nathan, Chris Dodds, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 10, 2018
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 GenotypeHisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 26, 2016
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 GenotypeHisham Ziauddeen, Liam J Nestor, Naresh Subramaniam, et al.
Pageof 2